Status:

COMPLETED

Treatment of Age-Related Macular Degeneration With Anecortave Acetate

Lead Sponsor:

Manhattan Eye, Ear & Throat Hospital

Collaborating Sponsors:

Alcon Research

Conditions:

Macular Degeneration

Eligibility:

All Genders

50+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to provide compassionate use of anecortave acetate sterile suspension of 15 mg for a series of five patients as a means to control classic neovascularization following fai...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of patients that previously had a failure of treatment with photodynamic therapy using Visudyne.
  • Patients must be at least 50 years of age.
  • Visual acuity of 20/30 to 20/320 in study eye on the Early Treatment of Diabetic Retinopathy Study (ETDRS) visual acuity chart
  • Visual acuity of 20/800 or better in fellow eye on the ETDRS visual acuity chart

Exclusion

  • Patient with significantly compromised visual acuity in the study eye due to concomitant ocular conditions.
  • Patients who have undergone intraocular surgery within the last 2 months.
  • Patient participating in any other investigational drug study.
  • Use of an investigational drug or treatment related or unrelated to their condition within 30 days prior to receipt of study medication.
  • Inability to obtain photographs to document choroidal neovascularization (CNV) (including difficulty with venous access).
  • Patient with significant liver disease or uremia.
  • Patient with known adverse reaction to fluorescein and indocyanine green or iodine.
  • Patient has a history of any medical condition which would preclude scheduled visits or completion of study
  • Patient has had insertion of scleral buckle in the study eye
  • Patient has received radiation treatment
  • Patient is on anticoagulant therapy with the exception of aspirin
  • Patient is pregnant or nursing.

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

End Date :

September 1 2007

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00211458

Start Date

September 1 2005

End Date

September 1 2007

Last Update

October 25 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Manhattan Eye, Ear & Throat Hospital

New York, New York, United States, 10021